Anika Therapeutics Inc. (ANIK)
NASDAQ · Healthcare
Anika Therapeutics Inc. Income Statement 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 112.8M | 119.9M | 120.8M | 113.8M | 147.8M | 130.5M | 114.6M | 105.6M | 113.4M | 103.4M | 93.0M | 105.6M | 75.1M | 71.4M | 64.8M | 55.6M | 40.1M |
| Gross Profit | 63.8M | 76.0M | 82.5M | 73.2M | 82.9M | 69.0M | 85.9M | 74.3M | 86.1M | 79.4M | 71.9M | 84.7M | 52.3M | 42.4M | 38.0M | 31.7M | 26.5M |
| Profitability | |||||||||||||||||
| Operating Income | -11.1M | -5.1M | 844,000 | 3.7M | 2.6M | -28.3M | 34.2M | 21.7M | 45.7M | 50.6M | 48.1M | 61.4M | 32.6M | 19.7M | 14.0M | 7.5M | 5.6M |
| EBITDA | -5.7M | 1.8M | 7.3M | 10.4M | 9.1M | -22.2M | 39.2M | 27.7M | 50.0M | 54.3M | 51.9M | 66.2M | 37.4M | 24.2M | 18.0M | 10.9M | 6.9M |
| Net Income | -10.9M | -56.4M | -82.7M | -14.9M | 4.1M | -24.0M | 27.2M | 18.7M | 31.8M | 32.5M | 30.8M | 38.3M | 20.6M | 11.8M | 8.5M | 4.3M | 3.7M |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 14M | 15M | 15M | 15M | 15M | 14M | 14M | 15M | 15M | 15M | 15M | 15M | 15M | 14M | 14M | 14M | 12M |
Anika Therapeutics Inc. Income Statement — FAQ
Anika Therapeutics Inc. (ANIK) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ANIK's income statement history?
The chart and table above show Anika Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.